The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Carlos A. Zarate

Experimental Therapeutics & Pathophysiology Branch

Division of Intramural Research Programs

National Institute of Mental Health

National Institutes of Health

USA

[email]@mail.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Experimental Therapeutics & Pathophysiology Branch, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, USA. 2007 - 2010
  • Laboratory of Molecular Pathophysiology and Experimental Therapeutics, Bethesda, Maryland, USA. 2005 - 2009
  • Mark O Hatfield CRC, Bethesda, Maryland 20892, USA. 2008
  • Mood and Anxiety Disorders Program, National Institute of Mental Health, Department of Human Health Services, Bethesda, USA. 2006

References

  1. Glutamatergic modulators: the future of treating mood disorders? Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., Salvadore, G. Harv. Rev. Psychiatry (2010) [Pubmed]
  2. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. Zarate, C.A., Manji, H.K. CNS. Drugs (2009) [Pubmed]
  3. Riluzole in psychiatry: a systematic review of the literature. Zarate, C.A., Manji, H.K. Expert. Opin. Drug. Metab. Toxicol (2008) [Pubmed]
  4. The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases. Zarate, C.A., Manji, H.K. Exp. Neurol. (2008) [Pubmed]
  5. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Zarate, C.A., Singh, J.B., Carlson, P.J., Quiroz, J., Jolkovsky, L., Luckenbaugh, D.A., Manji, H.K. Bipolar. Disord (2007) [Pubmed]
  6. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Zarate, C.A., Singh, J.B., Quiroz, J.A., De Jesus, G., Denicoff, K.K., Luckenbaugh, D.A., Manji, H.K., Charney, D.S. Am. J. Psychiatry (2006) [Pubmed]
  7. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Zarate, C.A., Singh, J., Manji, H.K. Biol. Psychiatry (2006) [Pubmed]
  8. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Zarate, C.A., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., Manji, H.K. Arch. Gen. Psychiatry (2006) [Pubmed]
  9. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Zarate, C.A., Quiroz, J.A., Singh, J.B., Denicoff, K.D., De Jesus, G., Luckenbaugh, D.A., Charney, D.S., Manji, H.K. Biol. Psychiatry (2005) [Pubmed]
 
WikiGenes - Universities